Simulations Plus

Simulations Plus is a leading company in the field of drug discovery and development, providing innovative solutions to improve health.

Simulations Plus develops software and leverages AI and machine learning for drug discovery and development, focusing on modeling and simulation tools. Their products include GastroPlus for pharmacokinetics, ADMET Predictor for molecular property prediction, and DDDPlus for dissolution analysis. The company offers solutions for physiologically-based pharmacokinetics, quantitative systems pharmacology, and population PK/PD modeling. They also provide consulting services to support pharmaceutical research, clinical trials, and regulatory submissions, helping clients improve drug development efficiency and success rates.

Schrödinger

Schrödinger is a leading company in the field of drug discovery that is transforming the way therapeutics and materials are discovered.

Schrödinger is a technology company that develops computational software for drug discovery and materials science. Their platform uses physics-based modeling to simulate molecular behavior, enabling researchers to explore billions of potential drug candidates efficiently.

PrecisionLife

PrecisionLife is a pioneering techbio company that is revolutionizing the field of drug discovery and personalized treatment selection.

PrecisionLife is a precision medicine company that uses advanced analytics and AI to uncover disease mechanisms in complex chronic conditions. They identify patient subgroups, discover novel drug targets, and develop personalized treatments.

Relay Therapeutics

Relay Therapeutics is a clinical-stage precision medicine company that is transforming the drug discovery process.

Relay Therapeutics is a clinical-stage precision medicine company that combines computational and experimental technologies to discover new drugs. Their platform integrates advanced computational methods with experimental approaches to address previously intractable or inadequately drugged protein targets.

Recursion Pharmaceuticals

Recursion Pharmaceuticals is a clinical-stage biotechnology company that is revolutionizing the field of drug discovery.

Recursion Pharmaceuticals is a biotechnology company that combines advanced technology with biological research to develop new medicines. They use large datasets of biological information, which they analyze using powerful computers and artificial intelligence. 

Valo Health

Valo Health is a technology company that is transforming the drug discovery and development process leveraging human-centric data and AI.

Valo Health is a technology company that transforms drug discovery and development using human-centric data and artificial intelligence. Valo integrates data across the entire drug development lifecycle into a unified architecture.

Lantern Pharma

Lantern Pharma is a clinical stage pharmaceutical company that is revolutionizing the field of oncology. They are pioneering the use of Artificial Intelligence, Machine Learning, and genomics to develop targeted cancer therapies.

Lantern Pharma is a clinical-stage biotechnology company that develops cancer therapies using artificial intelligence and machine learning. They focus on accelerating drug discovery and development by analyzing genomic data to identify potential treatments.

Insitro

Insitro is a company that stands at the intersection of human biology and machine learning redefining drug discovery and development.

Insitro is a drug discovery and development company that combines machine learning and high-throughput biology to create new medicines.The company uses artificial intelligence to analyze large-scale biological data, identify potential drug targets, and design more effective therapies.

Deep Genomics

Deep Genomics is in the field of drug discovery and development using AI to identify novel targets for therapeutic intervention.

Deep Genomics develops RNA-based therapies using artificial intelligence. Their AI platform analyzes genomic data to identify therapeutic targets and design drug candidates for genetic diseases. The company focuses on treating metabolic disorders and neurological conditions. Their proprietary technology, including the AI Workbench and BigRNA foundation model, enables efficient discovery of novel biological mechanisms and potential treatments that traditional methods might miss.

Cyclica

Cyclica is a trailblazer in the field of drug discovery, leveraging the power of artificial intelligence to develop new medicines.

Cyclica is a biotechnology company that uses artificial intelligence and computational biophysics to revolutionize drug discovery. Their innovative platform combines ligand design for multi-targeted drug creation and ligand express for off-target profiling. This approach allows for the efficient development of novel therapeutics while minimizing unwanted side effects. Cyclica’s technology enables faster, more cost-effective drug discovery processes, focusing on areas such as central nervous system disorders, oncology, and autoimmune diseases.